KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Vir Biotechnology (VIR) Receivables - Accured (2020 - 2024)

Vir Biotechnology's Revenue - Other history spans 6 years, with the latest figure at $1.9 million for Q1 2023.

  • On a quarterly basis, Revenue - Other fell 26.92% to $1.9 million in Q1 2023 year-over-year; TTM through Mar 2023 was $34.7 million, a 257.03% increase, with the full-year FY2022 number at $35.3 million, up 323.21% from a year prior.
  • Receivables - Accured hit $5.7 million in Q1 2024 for Vir Biotechnology, up from $4.0 million in the prior quarter.
  • Over the last five years, Receivables - Accured for VIR hit a ceiling of $5.7 million in Q1 2024 and a floor of $600000.0 in Q2 2021.
  • Historically, Receivables - Accured has averaged $2.1 million across 5 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Revenue - Other: crashed 92.78% in 2019 and later skyrocketed 777.69% in 2022.
  • Tracing VIR's Revenue - Other over 5 years: stood at $1.2 million in 2019, then skyrocketed by 576.92% to $8.1 million in 2020, then crashed by 61.26% to $3.1 million in 2021, then skyrocketed by 777.69% to $27.6 million in 2022, then crashed by 93.12% to $1.9 million in 2023.
  • Business Quant data shows Revenue - Other for VIR at $1.9 million in Q1 2023, $27.6 million in Q4 2022, and $3.1 million in Q3 2022.